Rohto Pharmaceutical CoLtd Pattern Recognition Counterattack

RPHCFDelisted Stock  USD 14.72  0.00  0.00%   
This pattern recognition tool runs Counterattack recognition and companion studies for Rohto Pharmaceutical. It emphasizes pattern recognition signals tied to momentum and continuation while keeping volatility, risk, and performance context in view.

Recognition
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Rohto Pharmaceutical Technical Analysis Modules

Most technical analysis of Rohto Pharmaceutical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Rohto from various momentum indicators to cycle indicators. When you analyze Rohto charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Pink Sheet Overview, Methodology & Data Sources

,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. ,Ltd. was founded in 1899 and is headquartered in Osaka, Japan. Rohto Pharmaceutical operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 6866 people. A high-level view of Rohto Pharmaceutical emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/E of 25.85, P/B of 2.57, profit margin of 10.71%. Rohto Pharmaceutical has a market cap of 4.15 B, P/E of 25.85, ROE of 12.5%.

Methodology

Unless otherwise specified, financial data for Rohto Pharmaceutical CoLtd is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Rohto (USA Stocks:RPHCF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Underlying inputs rely on public filings and market reference sources, including disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR. Values may reflect publication timing differences. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Rohto Pharmaceutical CoLtd may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on February 22nd, 2026

Become your own money manager

Tracking Rohto Pharmaceutical inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. That means looking at contribution to return, volatility, and correlation rather than relying on price movement alone.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Driverless Cars Idea
Driverless Cars
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Momentum Idea
Momentum
Invested few shares
ESG Investing Idea
ESG Investing
Invested few shares
Advertising Idea
Advertising
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Rohto Pharmaceutical has a market cap of 4.15 B, operating margin of 14.35%, ROE of 12.5%. Use Your Equity Center to explore allocation context. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.
With Rohto Pharmaceutical showing P/E 25.85 and ROE 12.5%, investors get more value when this analysis is combined with the diversification and construction tools below. Within the Consumer Defensive space, these metrics give the peer comparison tools below a concrete starting point for relative analysis. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Rohto Pink Sheet

Rohto Pharmaceutical trading may continue in OTC markets, though regulatory oversight differs from listed exchanges.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Valuation
Check real value of public entities based on technical and fundamental data